134 related articles for article (PubMed ID: 38339284)
1. Impact of KIR-HLA Genotype on Natural-Killer-Cell-Based Immunotherapy for Preventing Hepatocellular Carcinoma after Living-Donor Liver Transplantation.
Tanimine N; Ohira M; Kurita E; Nakano R; Sakai H; Tahara H; Ide K; Kobayashi T; Tanaka Y; Ohdan H
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339284
[TBL] [Abstract][Full Text] [Related]
2. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
[TBL] [Abstract][Full Text] [Related]
3. Quantitative effect of natural killer-cell licensing on hepatocellular carcinoma recurrence after curative hepatectomy.
Tanimine N; Tanaka Y; Kobayashi T; Tashiro H; Miki D; Imamura M; Aikata H; Tanaka J; Chayama K; Ohdan H
Cancer Immunol Res; 2014 Dec; 2(12):1142-7. PubMed ID: 25135909
[TBL] [Abstract][Full Text] [Related]
4. Human Leukocyte Antigen-C Genotype and Killer Immunoglobulin-like Receptor-Ligand Matching in Korean Living Donor Liver Transplantation.
Lee H; Park KH; Park HS; Ryu JH; Lim J; Kim Y; Na GH; Kim DG; Oh EJ
Ann Lab Med; 2017 Jan; 37(1):45-52. PubMed ID: 27834065
[TBL] [Abstract][Full Text] [Related]
5. Improved survival with inhibitory killer immunoglobulin receptor (KIR) gene mismatches and KIR haplotype B donors after nonmyeloablative, HLA-haploidentical bone marrow transplantation.
Symons HJ; Leffell MS; Rossiter ND; Zahurak M; Jones RJ; Fuchs EJ
Biol Blood Marrow Transplant; 2010 Apr; 16(4):533-42. PubMed ID: 19961944
[TBL] [Abstract][Full Text] [Related]
6. Donor killer immunoglobulin-like receptor genes and reactivation of cytomegalovirus after HLA-matched hematopoietic stem-cell transplantation: HLA-C allotype is an essential cofactor.
Behrendt CE; Nakamura R; Forman SJ; Zaia JA
Front Immunol; 2013; 4():36. PubMed ID: 23440333
[TBL] [Abstract][Full Text] [Related]
7. Investigation of Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes to Predict the Occurrence of Acute Allograft Rejection after Kidney Transplantation.
Jafari D; Nafar M; Yekaninejad MS; Abdolvahabi R; Lesan Pezeshki M; Razaghi E; Amirzargar AA
Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):245-255. PubMed ID: 28732438
[TBL] [Abstract][Full Text] [Related]
8. Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation.
Shilling HG; McQueen KL; Cheng NW; Shizuru JA; Negrin RS; Parham P
Blood; 2003 May; 101(9):3730-40. PubMed ID: 12511415
[TBL] [Abstract][Full Text] [Related]
9. Natural killer-cell activity after human renal transplantation in relation to killer immunoglobulin-like receptors and human leukocyte antigen mismatch.
Vampa ML; Norman PJ; Burnapp L; Vaughan RW; Sacks SH; Wong W
Transplantation; 2003 Oct; 76(8):1220-8. PubMed ID: 14578757
[TBL] [Abstract][Full Text] [Related]
10. Impact of killer-immunoglobulin-like receptor and human leukocyte antigen genotypes on the efficacy of immunotherapy in acute myeloid leukemia.
Bernson E; Hallner A; Sander FE; Wilsson O; Werlenius O; Rydström A; Kiffin R; Brune M; Foà R; Aurelius J; Martner A; Hellstrand K; Thorén FB
Leukemia; 2017 Dec; 31(12):2552-2559. PubMed ID: 28529313
[TBL] [Abstract][Full Text] [Related]
11. Donor and recipient HLA/KIR genotypes do not predict liver transplantation outcome.
Moroso V; van der Meer A; Tilanus HW; Kazemier G; van der Laan LJ; Metselaar HJ; Joosten I; Kwekkeboom J
Transpl Int; 2011 Sep; 24(9):932-42. PubMed ID: 21672051
[TBL] [Abstract][Full Text] [Related]
12. Donor and host coexpressing KIR ligands promote NK education after allogeneic hematopoietic stem cell transplantation.
Zhao XY; Yu XX; Xu ZL; Cao XH; Huo MR; Zhao XS; Chang YJ; Wang Y; Zhang XH; Xu LP; Liu KY; Huang XJ
Blood Adv; 2019 Dec; 3(24):4312-4325. PubMed ID: 31869417
[TBL] [Abstract][Full Text] [Related]
13. Impact of donor KIRs and recipient KIR/HLA class I combinations on GVHD in patients with acute leukemia after HLA-matched sibling HSCT.
Mansouri M; Villard J; Ramzi M; Alavianmehr A; Farjadian S
Hum Immunol; 2020 Jun; 81(6):285-292. PubMed ID: 32199702
[TBL] [Abstract][Full Text] [Related]
14. Recipient expression of ligands for donor inhibitory KIRs enhances NK-cell function to control leukemic relapse after haploidentical transplantation.
Zhao XY; Chang YJ; Zhao XS; Xu LP; Zhang XH; Liu KY; Li D; Huang XJ
Eur J Immunol; 2015 Aug; 45(8):2396-408. PubMed ID: 25952732
[TBL] [Abstract][Full Text] [Related]
15. Natural killer cells and killer cell immunoglobulin-like receptors in solid organ transplantation: Protectors or opponents?
Zamir MR; Shahi A; Salehi S; Amirzargar A
Transplant Rev (Orlando); 2022 Dec; 36(4):100723. PubMed ID: 35964414
[TBL] [Abstract][Full Text] [Related]
16. Donor with HLA-C2 is associated with acute rejection following liver transplantation in Southern Chinese.
Chen R; Yi H; Zhen J; Fan M; Xiao L; Yu Q; Yang Z; Ning L; Deng Z; Chen G
HLA; 2022 Aug; 100(2):133-141. PubMed ID: 35509131
[TBL] [Abstract][Full Text] [Related]
17. Killer Cell Immunoglobulin-like Receptors (KIR) and Human Leucocyte Antigen C (HLA-C) Increase the Risk of Long-Term Chronic Liver Graft Rejection.
Legaz I; Bolarín JM; Campillo JA; Moya-Quiles MR; Miras M; Muro M; Minguela A; Álvarez-López MR
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293011
[TBL] [Abstract][Full Text] [Related]
18. KIR gene mismatching and KIR/C ligands in liver transplantation: consequences for short-term liver allograft injury.
Legaz I; López-Álvarez MR; Campillo JA; Moya-Quiles MR; Bolarín JM; de la Peña J; Salgado G; Gimeno L; García-Alonso AM; Muro M; Miras M; Alonso C; Álvarez-López MR; Minguela A
Transplantation; 2013 Apr; 95(8):1037-44. PubMed ID: 23478359
[TBL] [Abstract][Full Text] [Related]
19. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
[TBL] [Abstract][Full Text] [Related]
20. Donor selection for killer immunoglobulin-like receptors B haplotype of the centromeric motifs can improve the outcome after HLA-identical sibling hematopoietic stem cell transplantation.
Zhou H; Bao X; Wu X; Tang X; Wang M; Wu D; He J
Biol Blood Marrow Transplant; 2014 Jan; 20(1):98-105. PubMed ID: 24516895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
